Lv3
264 积分 2022-09-05 加入
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab
12天前
已完结
Chimeric antigen receptor T-cell therapy and bispecific antibody sequence for large B-cell lymphoma: a systematic review and meta-analysis
26天前
已完结
Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?
1个月前
已完结
Building the future management of follicular lymphoma with T-cell–redirecting strategies
1个月前
已完结
Frontline treatment of follicular lymphoma: What will it take to change current practice?
1个月前
已完结
The future of follicular lymphoma management: strategies on the horizon
1个月前
已完结
Treatment of relapsed and refractory follicular lymphoma: which treatment for which patient for which line of therapy?
1个月前
已完结
The present and future for CAR-T cell therapy in adult B-cell ALL
3个月前
已完结
Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment
3个月前
已完结
Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation
5个月前
已完结
皖公网安备34019202002308
